Case report reveals adverse event of immune-mediated necrotizing myopathy in an adolescent following covid-19 vaccination, suggesting potential risks.
We discuss a teenager who developed a rare pediatric autoimmune muscle disease after completing the primary COVID‐19 vaccine series, which flared shortly after COVID‐19 booster vaccination. This case suggests that a rare chronic pediatric muscle disease may represent a possible adverse event related to COVID‐19 vaccination.
No takes yet. Share an insight, caveat, or question.
Hoffman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: